Skip to main content
2025 CRT Conference Main banner

CRT 2025

Digital Health and Artificial Intelligence

Panel Discussion | What do we Need to Consider for Adoption of new Software Devices?pact of Software Devices in Cardiology?

Monday, March 10, 2025
12:14 PM - 12:30 PM ET

    Panel Moderator(s)

  • Mona Advani, M.Sc., MBA

    Principal Regulatory Consultant
    CardioMed Device Consultants
    HERNDON, Virginia, United States

    No relationships to disclose

  • Richard E. Galgon, MD, MS

    Principal Consultant
    CardioMed Device Consultants, LLC
    Waunakee, Wisconsin, United States

    No relationships to disclose

    • Panel Discussant(s)

  • Mirvat Alasnag, MD, FSCAI, FACP, FACC, FSCCT

    Catheterization Laboratory Director & Deputy Head of Cardiology
    King Fahd Armed Forces Hospital
    Jeddah, Makkah, Saudi Arabia

    No relationships to disclose

  • Israel Barbash, MD

    Interventional Cardiologist
    Leviev Heart Center, Sheba Medical Center
    Shoham, HaMerkaz, Israel

    No relationships to disclose

  • Yair Feld, MD, PhD

    Director -Interventional cardiology
    Tzafon Medical Center (Poriya), Israel

    No relationships to disclose

  • Ramzi Khamis, MB ChB PhD FRCP FESC

    Consultant Cardiologist. Clinical Director of Cardiology and Cardiothoracic Surgery
    Imperial College London and Imperial College Healthcare NHS Trust
    London , England, United Kingdom

    No relationships to disclose

  • Chaim Shaul Lotan, MD

    Chief Innovation Officer
    Hadassah-Hebrew University Medical Center
    Jerusalem, Israel

    No relationships to disclose

  • Sa'ar Minha, MD

    Director, Interventional Cardiology
    Shamir Medical Center
    Shoham, Israel

    Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • Semih Oktay, PhD

    President
    Cardiomed Device Consultants
    Annapolis, Maryland, United States

    No relationships to disclose

  • Partha Sardar, MD

    Assistant Professor
    Columbia University

    Disclosure(s): No financial relationships to disclose

  • Jason Wasfy, MD

    Director of Outcomes Research
    Massachusetts General Hospital
    Cambridge, Massachusetts, United States

    Disclosure(s): No financial relationships to disclose

Disclosure(s):
Mona Advani, M.Sc., MBA: No financial relationships to disclose
Richard E. Galgon, MD, MS: No financial relationships to disclose
Mirvat Alasnag, MD, FSCAI, FACP, FACC, FSCCT: No financial relationships to disclose
Israel Barbash, MD: No financial relationships to disclose
Yair Feld, MD, PhD: No financial relationships to disclose
Ramzi Khamis, MD PhD: No financial relationships to disclose
Chaim Shaul Lotan, MD: No financial relationships to disclose
Sa'ar Minha, MD: Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Semih Oktay, PhD: I am a regulatory consultant to many cardiovascular device manufacturers: Consultant (Ongoing)
Partha Sardar, MD: No financial relationships to disclose
Jason Wasfy, MD: No financial relationships to disclose